Federal Register / Vol. 83, No. 161 / Monday, August 20, 2018 / Notices 42123 

including any personal and/or business 

confidential information provided. To 

confirm receipt of your comment(s), 

please check regulations.gov, 

approximately two-to-three business 

days after submission to verify posting 

(except allow 30 days for posting of 

comments submitted by mail). 

FOR FURTHER INFORMATION CONTACT: Mr. 

Curtis E. Glover, Sr., Procurement 

Analyst, Office of Governmentwide 

Acquisition Policy, GSA 202–501–1448 

or via email at curtis.glover@gsa.gov. 

SUPPLEMENTARY INFORMATION: 

A. Purpose 

FAR Part 47 contains policies and 

procedures for applying transportation 

and traffic management considerations 

in the acquisition of supplies. The FAR 

part also contains policies and 

procedures when acquiring 

transportation or transportation-related 

services. Generally, contracts involving 

transportation require information 

regarding the nature of the supplies, 

method of shipment, place and time of 

shipment, applicable charges, marking 

of shipments, shipping documents and 

other related items. Contractors are 

required to provide the information in 

accordance with the following FAR Part 

47 clauses: 52.247–29 through 52.247– 

44, 52.247–48, 52.247–52, and 52.247– 

64. The information is used to ensure 

that: (1) Acquisitions are made on the 

basis most advantageous to the 

Government and; (2) supplies arrive in 

good order and condition, and on time 

at the required place. 

B. Annual Reporting Burden 

Respondents: 65,000. 

Responses per Respondent: 22. 

Annual Responses: 1,430,000. 

Hours per Response: .05. 

Total Burden Hours: 71,500. 

C. Public Comments 

A 60-day notice was published in the 

Federal Register at 83 FR 15571 on 

April 11, 2018. No comments were 

received. Public comments are 

particularly invited on: Whether this 

collection of information is necessary; 

whether it will have practical utility; 

whether our estimate of the public 

burden of this collection of information 

is accurate, and based on valid 

assumptions and methodology; ways to 

enhance the quality, utility, and clarity 

of the information to be collected; and 

ways in which we can minimize the 

burden of the collection of information 

on those who are to respond, through 

the use of appropriate technological 

collection techniques or other forms of 

information technology. 

Obtaining Copies of Proposals: 

Requesters may obtain a copy of the 

information collection documents from 

the General Services Administration, 

Regulatory Secretariat Division (MVCB), 

1800 F Street NW, Washington, DC 

20405, telephone 202–501–4755. 

Please cite OMB Control No. 9000– 

0061, Transportation Requirements, in 

all correspondence. 

William Clark, 

Director, Office of Governmentwide 

Acquisition Policy, Office of Acquisition 

Policy, Office of Governmentwide Policy. 

[FR Doc. 2018–17929 Filed 8–17–18; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Office on Trafficking in Persons; 

Notice of Meeting 

AGENCY: Administration for Children 

and Families (ACF), Department of 

Health and Human Services. 

ACTION: Announcement of meeting. 

SUMMARY: Notice is hereby given, 

pursuant to the provisions of the 

Federal Advisory Committee Act 

(FACA) and the Preventing Sex 

Trafficking and Strengthening Families 

Act, that a meeting of the National 

Advisory Committee (NAC) on the Sex 

Trafficking of Children and Youth in the 

United States (Committee) will be held 

on September 13–14, 2018. The purpose 

of the meeting is for the Committee to 

discuss its duties and information for a 

draft report on recommended best 

practices for states to follow in 

combating the sex trafficking of children 

and youth based on multidisciplinary 

research and promising, evidence-based 

models and programs. 

DATES: The meeting will be held on 

Thursday, September 13, 2018, from 

9:00 a.m. to 5:00 p.m. ET and on Friday, 

September 14, 2018, from 9:00 a.m. to 

1:00 p.m. ET. 

ADDRESSES: The meeting will be held at 

200 Independence Ave. SW, 

Washington, DC 20201. Space is 

limited. Identification will be required 

at the entrance of the facility (e.g., 

passport, state ID, or federal ID). 

To attend the meeting virtually, 

please register for this event online: 

https://www.acf.hhs.gov/otip/resource/ 

nacagenda0918. 

FOR FURTHER INFORMATION CONTACT: 

Katherine Chon, Director, Office on 

Trafficking in Persons, Designated 

Federal Officer (DFO) at 

EndTrafficking@acf.hhs.gov or (202) 

205–4554 or 330 C Street SW, 

Washington, DC 20201. Additional 

information is available at https://

www.acf.hhs.gov/otip/partnerships/thenational-advisory-committee. 

SUPPLEMENTARY INFORMATION: The 

formation and operation of the NAC are 

governed by the provisions of Public 

Law 92–463, as amended (5 U.S.C. App. 

2), which sets forth standards for the 

formation and use of federal advisory 

committees. 

Purpose of the NAC: The purpose of 

the NAC is to advise the Secretary and 

the Attorney General on practical and 

general policies concerning 

improvements to the nation’s response 

to the sex trafficking of children and 

youth in the United States. The NAC is 

established pursuant to Section 121 of 

the Preventing Sex Trafficking and 

Strengthening Families Act of 2014 (P.L. 

113–183). 

Tentative Agenda: The agenda can be 

found at https://www.acf.hhs.gov/otip/ 

resource/nacagenda0918. 

Public Accessibility to the Meeting: 

Pursuant to 5 U.S.C. 552b and 41 CFR 

102–3.140 through 102–3.165, and 

subject to the availability of space, this 

meeting is open to the public. Seating is 

on a first to arrive basis. Because the 

meeting of the NAC will be held at 200 

Independence Ave. SW, Washington, 

DC 20201, security screening is 

required. Attendees are requested to 

register by submitting their name, 

affiliation, email address, and daytime 

phone number 10 business days prior to 

the meeting by email to: adonald@

nhttac.org. A photo ID is required to 

enter the premises. Please note that 

space and parking is limited. The 

building is fully accessible to 

individuals with disabilities. 

Written Comments or Statements: 

Pursuant to 41 CFR 102–3.105(j) and 

102–3.140 and section 10(a)(3) of the 

FACA, the public or interested 

organizations may submit written 

comments or statements to the NAC in 

response to the stated agenda of the 

meeting or in regard to the committee’s 

mission in general. Written comments 

or statements should be addressed to 

Katherine Chon, the NAC DFO, via 

email, the preferred mode of 

submission, at adonald@nhttac.org. The 

DFO will review all submitted written 

comments or statements and provide 

them to members of the NAC for 

consideration in advance of the meeting. 

Written comments or statements 

submitted in response to the agenda set 

forth in this notice must be received by 

the DFO at least 15 business days prior 


daltland on DSKBBV9HB2PROD with NOTICES
42124 Federal Register / Vol. 83, No. 161 / Monday, August 20, 2018 / Notices 

to the meeting to be considered by the 

NAC. Written comments or statements 

received after this date may not be 

provided to the NAC until its next 

meeting. 

Verbal Comments or Statements: 

Pursuant to 41 CFR 102–3.140d, the 

NAC is not obligated to allow a member 

of the public to speak or otherwise 

address the NAC during the meeting. 

Members of the public are invited to 

provide verbal comments or statements 

during the NAC meeting only at the 

time and manner described below. All 

requests to speak or otherwise address 

the NAC during the meeting must be 

submitted to the NAC’s DFO at least 15 

days prior to the meeting, via email, the 

preferred mode of submission, at 

adonald@nhttac.org. The request should 

include a brief statement of the subject 

matter to be addressed by the comment 

and should be relevant to the stated 

agenda of the meeting or in regard to the 

NAC’s mission in general. The DFO will 

log each request in the order received. 

A period near the end of the meeting 

will be available for verbal public 

comments. The time allotted will 

depend on the number of public 

comments or statements received and 

the NAC’s agenda items. To provide 

time for as many people to speak as 

possible, speaking time for each 

individual will be limited to 3 minutes. 

Minutes: The minutes of this meeting 

will be available for public review and 

copying within 90 days at: https://

www.acf.hhs.gov/otip/partnerships/thenational-advisory-committee. 

Dated: August 14, 2018. 

Steven Wagner, 

Acting Assistant Secretary for Children and 

Families. 

[FR Doc. 2018–17891 Filed 8–17–18; 8:45 am] 

BILLING CODE 4184–40–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2018–N–1558] 

Food and Drug Administration’s 

Evaluation of Approaches To 

Demonstrate Effectiveness of 

Heartworm Preventatives for Dogs; 

Extension of Comment Period 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice; request for comments; 

extension of comment period. 

SUMMARY: The Food and Drug 

Administration (FDA or the Agency) is 

extending the comment period for the 

request for comments that appeared in 

the Federal Register of May 24, 2018. In 

the request for comments, FDA 

requested comments on the design of 

studies intended to generate data to 

support substantial evidence of 

effectiveness for investigational new 

animal drugs intended for the 

prevention of heartworm disease in 

dogs. The Agency is taking this action 

in response to requests for an extension 

to allow interested persons additional 

time to submit comments. 

DATES: FDA is extending the comment 

period on the request for comments 

published May 24, 2018 (83 FR 24122). 

Submit either electronic or written 

comments by November 20, 2018. 

ADDRESSES: You may submit comments 

as follows. Please note that late, 

untimely filed comments will not be 

considered. Electronic comments must 

be submitted on or before November 20, 

2018. The https://www.regulations.gov 

electronic filing system will accept 

comments until midnight Eastern Time 

at the end of November 20, 2018. 

Comments received by mail/hand 

delivery/courier (for written/paper 

submissions) will be considered timely 

if they are postmarked or the delivery 

service acceptance receipt is on or 

before that date. 

Electronic Submissions 

Submit electronic comments in the 

following way: 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

Comments submitted electronically, 

including attachments, to https://

www.regulations.gov will be posted to 

the docket unchanged. Because your 

comment will be made public, you are 

solely responsible for ensuring that your 

comment does not include any 

confidential information that you or a 

third party may not wish to be posted, 

such as medical information, your or 

anyone else’s Social Security number, or 

confidential business information, such 

as a manufacturing process. Please note 

that if you include your name, contact 

information, or other information that 

identifies you in the body of your 

comments, that information will be 

posted on https://www.regulations.gov. 

• If you want to submit a comment 

with confidential information that you 

do not wish to be made available to the 

public, submit the comment as a 

written/paper submission and in the 

manner detailed (see ‘‘Written/Paper 

Submissions’’ and ‘‘Instructions’’). 

Written/Paper Submissions 

Submit written/paper submissions as 

follows: 

• Mail/Hand delivery/Courier (for 

written/paper submissions): Dockets 

Management Staff (HFA–305), Food and 

Drug Administration, 5630 Fishers 

Lane, Rm. 1061, Rockville, MD 20852. 

• For written/paper comments 

submitted to the Dockets Management 

Staff, FDA will post your comment, as 

well as any attachments, except for 

information submitted, marked and 

identified, as confidential, if submitted 

as detailed in ‘‘Instructions.’’ 

Instructions: All submissions received 

must include the Docket No. FDA– 

2018–N–1558 for ‘‘FDA’s Evaluation of 

Approaches to Demonstrate 

Effectiveness of Heartworm 

Preventatives for Dogs.’’ Received 

comments, those filed in a timely 

manner (see ADDRESSES), will be placed 

in the docket and, except for those 

submitted as ‘‘Confidential 

Submissions,’’ publicly viewable at 

https://www.regulations.gov or at the 

Dockets Management Staff between 9 

a.m. and 4 p.m., Monday through 

Friday. 

• Confidential Submissions—To 

submit a comment with confidential 

information that you do not wish to be 

made publicly available, submit your 

comments only as a written/paper 

submission. You should submit two 

copies total. One copy will include the 

information you claim to be confidential 

with a heading or cover note that states 

‘‘THIS DOCUMENT CONTAINS 

CONFIDENTIAL INFORMATION.’’ The 

Agency will review this copy, including 

the claimed confidential information, in 

its consideration of comments. The 

second copy, which will have the 

claimed confidential information 

redacted/blacked out, will be available 

for public viewing and posted on 

https://www.regulations.gov. Submit 

both copies to the Dockets Management 

Staff. If you do not wish your name and 

contact information to be made publicly 

available, you can provide this 

information on the cover sheet and not 

in the body of your comments and you 

must identify this information as 

‘‘confidential.’’ Any information marked 

as ‘‘confidential’’ will not be disclosed 

except in accordance with 21 CFR 10.20 

and other applicable disclosure law. For 

more information about FDA’s posting 

of comments to public dockets, see 80 

FR 56469, September 18, 2015, or access 

the information at: https://www.gpo.gov/ 

fdsys/pkg/FR-2015-09-18/pdf/2015- 

23389.pdf. 

Docket: For access to the docket to 

read background documents or the 

electronic and written/paper comments 

received, go to https://

www.regulations.gov and insert the 

docket number, found in brackets in the 


daltland on DSKBBV9HB2PROD with NOTICES